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Continuous quality improvement efforts have become
a central focus of leading health care organizations.
The transplant community has been a pioneer in peri-
odic review of clinical outcomes to ensure the optimal
use of limited donor organs. Through data collected
from the Organ Procurement and Transplantation Net-
work (OPTN) and analyzed by the Scientific Registry
of Transplant Recipients (SRTR), transplantation pro-
fessionals have intermittent access to specific, accu-
rate and clinically relevant data that provides infor-
mation to improve transplantation. Statistical process
control techniques, including cumulative sum charts
(CUSUM), are designed to provide continuous, real-
time assessment of clinical outcomes. Through the
use of currently collected data, CUSUMs can be con-
structed that provide risk-adjusted program-specific
data to inform quality improvement programs. When
retrospectively compared to currently available data re-
porting, the CUSUM method was found to detect clin-
ically significant changes in center performance more
rapidly, which has the potential to inform center lead-
ership and enhance quality improvement efforts.
Key words: Quality assessment, risk assessment mod-
eling, SRTR/OPTN, statistical methodology
Introduction
Continuous quality improvement programs have emerged
as key components of high-performing health care orga-
nizations. The collection and timely analysis of clinically
relevant data is crucial in accomplishing quality improve-
ment initiatives and ensuring the highest quality care for
patients. Organ transplantation is unique among medical
specialties in the quantity and quality of data collected on
a national basis. Through data collected from the Organ
Procurement and Transplantation Network (OPTN), accu-
rate and clinically relevant data are available that can pro-
vide information to improve transplantation outcomes. Cur-
rently, however, these data are analyzed on an episodic
basis and provided to centers semiannually through the
Program-Specific Reports (PSRs). Consequently, recogni-
tion of clinically relevant changes in clinical outcomes may
be delayed, limiting the success of quality improvement
efforts.
Statistical process control charts were originally developed
to study industrial processes in the 1930s by W.A. She-
whart and his colleagues at Bell Laboratories (1). These
charts measure performance over time and ‘signal’ if there
is a deviation from accepted production standards. The
CUSUM, or cumulative sum, chart was introduced in 1954
by Page and provided a very sensitive approach to moni-
toring a process and identifying changes in outcome (2).
The purpose of these charts is to give timely and easily
interpreted summaries of outcome data. The potential util-
ity of CUSUMs in health care was recognized in the early
1970s when the paper, ‘Why don’t doctors use CUSUM?’
was published in the Lancet (3). Several years later, the
New England Journal of Medicine published a manuscript,
which highlighted the value of CUSUM techniques in clini-
cal applications (4). Broad acceptance of these techniques,
however, was delayed initially by data collection limitations
and subsequently by the inability to include meaningful risk
adjustment.
Recent high-profile events, including a cluster of heart
transplant deaths in Britain (5) and the Institute of
Medicine’s report, ‘Crossing the Quality Chasm’ (6), have
contributed to a heightened awareness of the need to mon-
itor surgical outcomes. Public interest and recent improve-
ments in the analytic methods have led to rapid increases
in the utilization of CUSUMs to track surgical outcomes. In
a 2007 review, Biau and colleagues identified 31 studies
which utilized CUSUMs to track surgical outcomes in car-
diac, general and ENT surgery (7). Other work on CUSUM
methods and applications in medical studies can be found
in various statistical and medical journals (8–10).
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Application of CUSUMs to the management of transplant
centers offers physician leaders the opportunity to track
outcomes in a real-time, risk-adjusted manner. A previous
retrospective analysis demonstrated that CUSUMs iden-
tified changes in clinical practice sooner and with higher
sensitivity than current center monitoring techniques (11).
Recent improvements in chart construction are based on
survival analysis techniques and allow the incorporation of
outcomes as they occur, rather than after passage of a
specific time period (e.g. 1-year posttransplant) as had pre-
viously been the case (12). Furthermore, these CUSUM
charts are risk adjusted using comprehensive models
currently employed by the SRTR to adjust outcomes for
patient and donor characteristics and are adjusted for pa-
tient mix. In general, the CUSUM compares observed out-
comes with expected results; it increases in value as graft
failures or patient deaths occur and decreases during pe-
riods with no failures. If too many failures occur over time
(compared to what would be expected) the value of the
CUSUM will exceed a predetermined threshold value and
‘signal’ that a process review should be initiated.
This article provides a brief overview of the construction
and application of CUSUM charts for transplant profession-
als. We begin with a brief summary of the construction
and interpretation of CUSUM charts, including a number
of examples. Following this, we briefly review the methods
currently used by the SRTR to assess transplant programs
in the PSRs. Next, we present a retrospective comparison
of CUSUM monitoring with the techniques employed in
the PSRs. Finally, we address the strengths as well as po-
tential difficulties and risks of a broad application of this
technique.
Defining CUSUMs
A CUSUM chart for a given program or center presents
a simple graphical comparison of observed and expected
numbers of events over time. In their initial description of
a clinically relevant, risk-adjusted CUSUM, Steiner et al.
and Grigg et al. described methods for assessing perfor-
mance of a clinical system that produced a binary outcome
(e.g. death following cardiac surgery) (10,13,14). In these
methods, the CUSUM is increased or decreased by a vari-
able degree depending upon the observed and expected
outcomes from the process. Axelrod et al. applied this ap-
proach to transplant data and developed CUSUM charts to
monitor 1-year posttransplant survival for liver transplant
recipients and 1-year allograft survival for kidney transplant
recipients (11). Based on the method of Steiner et al. (13),
a logistic regression model, which included several donor
and recipient factors, was utilized for risk adjustment.
Binary outcome CUSUM charts are very useful tools for
monitoring situations in which the outcome is binary and
rapidly ascertained; for example, in monitoring conversion
rates (the percentage of possible donors which actually
result in transplantable organs), acceptance rates (the per-
centage of organ offers which are accepted by a program)
or mortality rates over a short, fixed period of time. They
do have a disadvantage: in monitoring longer term survival
outcomes such as 1- or 2-year mortality rates, the data on
any given individual cannot be used until the corresponding
period has elapsed.
In 2008, Biswas and Kalbfleisch developed a method to
create risk-adjusted CUSUM charts that are based on a
continuous time survival analysis approach and are able
to incorporate deaths or graft failures as they occur (12).
These charts have a substantial advantage in the monitor-
ing of longer term survival endpoints and are more con-
sistent with the Cox model-based risk-adjusted methods
used by the SRTR. This method can be utilized to construct
two types of CUSUM methods: a one-sided chart in which
the value is restricted to nonnegative sums and a two-
sided or O-E chart, as described below; a more complete
description of the calculation of the CUSUMs is included
in the Appendix.
The one-sided CUSUM: It is constructed principally to
assess for a clinically significant excess of allograft failures
or patient deaths. The CUSUM is restricted to positive val-
ues and so is bounded below at a value of zero. Thus,
a center performing at, or better than, the expected per-
formance (and thus having fewer observed failures than
expected) would have a chart which tends to stay rela-
tively close to zero. It would increase with any failure, and
then return to zero in an ensuing period without failures.
Conversely, if the center’s outcomes are much poorer than
the national average, the number of failures will lead to a
substantial increase in the CUSUM and this will eventu-
ally result in a signal. The one-sided CUSUM signals when
the plot line crosses a horizontal line, termed the control
limit, which defines the signaling threshold. The height of
this line (L) reflects the balance between rapid signaling
that will very quickly identify centers with poor outcomes
(sensitivity) and the desirability of avoiding false positive
results (specificity) and signaling when the center’s per-
formance is actually consistent with the national average.
The value of L can be adjusted for center volume to ensure
that the sensitivity is kept at a suitably low level for all cen-
ters. Figures 1–3 (bottom panels) provide examples of the
one-sided CUSUM. In our analysis, if a kidney transplant
center’s volume is 40 transplants/year or more and its true
rate is twice the adjusted national average, the chance of a
signal over a 3-year period is 90% or more. If the center’s
rates are the same as the national average, a period of
30 years would be expected before the first false positive
signal.
The two-sided or O-E CUSUM: For a given center, this
simplest of CUSUM plots, as a function of time, the dif-
ference between the observed number of deaths and the
number of deaths that would be expected based on the
risk-adjusted national average. This CUSUM can be viewed
as being updated daily by adding to its previous value the
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Figure 1. Panel A1 (top): O-E CUSUM
chart for 1-year mortality in the liver
program at Center A, which had 200
liver transplants within a 3.5-year
period. Panel A2 (bottom): One-sided
CUSUM chart for 1-year follow-up in the
liver program at Center A.

























































Figure 2. Panel B1 (top): O-E CUSUM
chart for the liver program at Cen-
ter B, which had 256 liver transplants
within the 3.5-year period. Panel B2
(bottom): One-sided CUSUM chart for
the liver program at Center B.
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Figure 3. Panel C1 (top): O-E
CUSUM chart for the liver program
at Center C, which had 414 liver
transplants within the 3.5-year pe-
riod. Panel C2 (bottom): One-sided
CUSUM chart for the liver program
at Center C.
observed number of deaths on that day less the expected
number. The expected number of deaths is estimated from
a survival model based on national data and is adjusted for
the particular patient mix at the center. Thus, the O-E chart
traces out an approximately horizontal path (slope = 0) if
the death rate at the center is close to the risk-adjusted
national average. An upward trend of the O-E plot over a
specified time interval indicates that the center has worse
outcomes than the adjusted national average. Conversely,
a downward trend of the plot corresponds to better out-
comes than the adjusted national average. Figures 1–3 (top
panel) provide examples of O-E plots and are discussed fur-
ther below. As indicated by the arrows superimposed on
the plots, the ‘slope’ of the plot gives an estimate of the ap-
proximate relative risk (RR), which is the ratio of the death
rate at the center to that for the adjusted national average.
It is possible to use the two-sided CUSUM to provide a
signal when there is statistical evidence that a center’s
outcomes are different from the national average. The two-
sided CUSUM signals if the ‘slope’ of the plot exceeds a
predetermined value over an extended period. The signal
is obtained by systematically checking the slope of the
plot at each successive time using a V-mask as introduced
by Barnard (15,16) and discussed in the Appendix. As in
the height of L in the one-sided chart, the angle of slope,
which is considered significant in the two-sided chart, can
be adjusted to balance sensitivity and specificity.
The principal advantage of the O-E plot is that the slope
of the plot over a given interval gives an immediate pic-
ture of the relative rate of outcomes within the center of
interest compared to expected results. In the one-sided
CUSUM, the slope of the chart is more difficult to interpret
and immediate comparisons to the national average or ex-
pected results are more difficult to see. We find that both
charts provide useful and complementary information, as
the examples in the next subsection illustrate.
Examples of CUSUM charts and interpretation
A sample of CUSUM charts over a 3-year period for liver
transplant programs, labeled Center A, Center B and Cen-
ter C, is described here. For each center, the one-sided
CUSUM and O-E CUSUM charts are presented for 1-year
patient survival. Similar charts could be constructed for
graft survival or for other outcomes such as 1-month or
2-year survival.
Center A: From the O-E chart, the failure rate for the 1-
year survival in Center A is close to the national average
for the first year, as is suggested by the nearly horizontal
plot line (slope approximately 0) (Figure 1). For the second
period, from 1 to 3.5 years, the death rate exceeded the
national average, as illustrated by an increase in the slope
of the O-E CUSUM. From the one-sided CUSUM chart
(Figure 1), we see that these trends would have led to a
signal at the end of the second year. If the chart had been
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in place, this signal suggests a review of center practices
may be appropriate.
Center B: The O-E chart in Figure 2 illustrates that Cen-
ter B experienced death rates very close to the national
average (adjusted for patient mix) over the first 2 years of
the CUSUM period. During the last 1.5 years, the center
had considerably better 1-year outcomes than the adjusted
national average. Correspondingly, the one-sided CUSUM
chart (Figure 2) did not signal.
Center C: From the O-E chart (Figure 3), we see that the
1-year mortality at the center was higher than the national
average for the first year or so. After that period, the 1-
year death rates were considerably lower than the adjusted
national rates through the end of the 3.5-year period. From
the one-sided CUSUM (Figure 3), we see that the higher
death rates observed early on were not sufficient to lead
to a signal.
Current Methods of Risk Adjustment and
Quality Assessment: SRTR Processes
Although there is no ‘gold standard’ for performance as-
sessment, the methods utilized in the PSRs prepared
by the SRTR for the United Network for Organ Sharing
(UNOS) Membership and Professional Standards Commit-
tee (MPSC) provide an important benchmark for compar-
ison (17). However, it is important to keep in mind a key
difference between the CUSUM methods discussed here
and the PSRs. The PSRs are a regulatory tool used to
help ensure compliance with current performance stan-
dards; they are not intended nor constructed to be used
as a quality improvement instrument. The PSRs supplied
by the SRTR help the MPSC identify transplant programs
or organ procurement organizations (OPOs) that might re-
quire site visits or case reviews to look more deeply into
potential problems, whereas the CUSUM procedures can
be used by the center directors themselves for real-time
monitoring and quality improvement efforts.
Broadly speaking, the MPSC seeks to identify programs
that experience significant deviations from expected per-
formance measures related to the care of wait-listed and
transplanted patients. Centers identified are characterized
as needing further review if they meet the following
criteria:
• Clinical outcome failures that exceed predetermined
thresholds relative to expected performance. Currently
the thresholds include an excess death rate of at least
50% (Observed/Expected > 1.5);
• A clinically important number of incidences, defined as
an absolute number of excess deaths greater than 3;
• Statistical confidence that the observed difference be-
tween observed and expected results is unlikely to have
occurred by chance (one-tailed P-value < .05).
The SRTR utilizes a robust data set including all observed
events during the time a patient is actually followed, either
by the center and the OPTN or through other data sources
including the Social Security Death Master File. Kidney
graft survival data are supplemented by examination of
claims data related to return to dialysis from the Centers
for Medicare & Medicaid Services (CMS). This method-
ology essentially eliminates the possibility of uncaptured
recipient death or kidney allograft failure events.
All data provided to the MPSC are risk-adjusted using Cox
proportional hazards regression models, including donor
data, recipient characteristics and transplant variables. For
example, for the 1-year deceased donor adult kidney pa-
tient survival model, the proportion of the variation ex-
plained by the model was 73% for the July 2008 release. It
is important to note that the SRTR models used by the
MPSC do not adjust for perioperative or posttransplant
management practices (e.g. type of induction and immuno-
suppression). These factors, while clearly influencing out-
comes, are within the control of the transplant center and
contribute to the center’s performance that is examined
by the MPSC. The models are designed to control for dif-
ferences in the underlying recipient severity of illness and
donor quality, which are largely determined by the location
of the center and the donor characteristics within the OPO.
The program-review criteria were set by the MPSC in order
to facilitate identification of programs for which interven-
tions were likely to have a demonstrable clinical impact.
The criteria are stringent to reduce the risk of a false pos-
itive finding in which outcomes vary from those expected
by chance alone. Because smaller centers with poor out-
comes may not meet the three thresholds despite poor
outcomes, all centers performing nine or fewer transplants
in a 2.5-year cohort are evaluated by a separate standard,
whose only criterion is at least one adverse event (graft
failure or death). The review thresholds for both small and
large programs are reviewed periodically by the SRTR and
the MPSC.
The MPSC examines quarterly data on a 2.5-year rolling
average of outcomes. In order to have complete data
on 1-year survival, for example, the PSRs for the MPSC
and center directors are somewhat time delayed. Con-
sequently, these analytic techniques are not well suited
to day-to-day management of transplant center outcomes
by center directors. Previous analyses have demonstrated
that significant clusters of surgical failures may be missed
utilizing only episodic analysis of average outcomes, par-
ticularly for large centers. Given the regulatory and legal
implications of MPSC actions, criteria that are highly reli-
able and very specific are crucial. However, for the purpose
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of center management, a sensitive, continuous, up-to-date
outcomes tracking tool would allow better assessment
of center performance. CUSUM techniques may comple-
ment the PSRs, and would potentially allow center direc-
tors to determine trends in performance in an expedited
manner.
Application to Liver and Kidney Outcome
Assessment Using the OPTN Database
To assess the potential value of CUSUM monitoring of
transplant center performance, we performed retrospec-
tive analyses of 1-year patient survival at liver and 1-year
graft survival at kidney transplant centers. Two separate
charts were constructed to detect declining center perfor-
mance: a one-sided continuous CUSUM chart and an O-E
CUSUM chart with a V-mask (see Appendix). For each cen-
ter, the value of L and the slope of the V-mask were defined
so that they would provide a signal approximately 8% of
the time in a 3.5-year period in centers of the same size
whose 1-year survival rates are identical to the overall na-
tional average. This ‘false positive rate’ is equivalent to the
false positive rate that would arise from the methods used
to prepare the PSRs.
Data sources
Data from the cohort of recipients of deceased donor trans-
plants between July 1, 2004, and December 31, 2007,
were reviewed for kidney and liver transplant programs in
the OPTN database. The data included 11,957 liver trans-
plant recipients transplanted at 67 centers, which ranged
in size from 1 to 185 liver transplants per year over the
3.5-year period. We omitted nine centers with less than
eight transplants per year, for which the CUSUMs would
be expected to yield little power. The SRTR models for
posttransplant survival used for the PSRs were used to de-
termine the expected number of failures risk-adjusted to
correspond to the center’s donor and recipient characteris-
tics. The SRTR’s 1-year survival model for liver transplants
from a deceased donor adjusts for 23 donor and recipient
characteristics, whereas the model for living donor liver
transplants adjusts for seven donor and recipient charac-
teristics. This study was approved by Health Resources
and Services Administration’s (HRSA) SRTR project officer.
HRSA has determined that this study satisfies the criteria
for the IRB exemption described in the ‘Public Benefit and
Service Program’ provisions of 45 CFR 46.101(b)(5) and
HRSA Circular 03.
We also considered results from 113 kidney transplant
programs that included 31,666 recipients transplanted be-
tween July 1, 2004, and December 31, 2007. These pro-
grams had average volumes of 1 to 278 deceased and living
donor kidney transplants per year. We included the facilities
with 8 to 220 transplants per year in our study and grouped
them into six categories. This omitted 11 small programs
with fewer than 8 transplants per year, and two large cen-
ters with 278 and 225 transplants per year. Again, we uti-
lized the SRTR’s PSR models to represent national rates
for graft failure; the model for deceased (living) donors in-
cludes 22 (13) donor and recipient characteristics. Details
of both the liver and the kidney models can be found on
the SRTR website (www.ustransplant.org).
For each program, the control limit L and V-mask were
defined based on the center’s volume (see Appendix) and
it was determined whether the CUSUMs produced a signal
(or flag). In addition, a benchmark was based on a review
of the PSRs to determine whether or not a flag occurred
for each program in the study. The time to flagging for the
PSR was taken as 3 or 3.5 years depending on whether the
flag occurred in the January 2008 or the July 2008 report.
Results
Results of this comparison are presented for five-volume
strata for liver transplant programs (Table 1). There is very
close agreement between the CUSUM methods; in fact,
they both identified exactly the same centers and at almost
identical times. However, the results differed slightly from
those obtained from the current PSR approach. There were
two centers that were flagged by the CUSUMs that were
not identified by the PSR approach due to clusters of surgi-
cal failures, which were not captured using the PSR meth-
ods. For the centers which were flagged as having below-
expected performance, the average time needed to reach
the signal point was less than 2 years for the CUSUMs,
compared to more than 3 years for the PSR approach. In
this case, the CUSUMs signaled slightly more often than
the SRTR’s PSR approach (12 versus 10).
Similar results were generated when these methods were
applied to the 100 kidney transplant programs using 1-year
graft survival as the outcome of interest (Table 2). In this
case, both CUSUMs signaled at the same 21 centers, com-
pared to nine centers that were flagged by the PSR. Here
again, the average time to signal was much shorter for
the two CUSUM approaches. In the 12 centers signaled
in the CUSUMs, but not in the PSR, only eight slightly ex-
ceeded the control limit, one signaled after 3 years when
the PSRs are not fully complete, and the other three cen-
ters exceeded the control limit by a substantial amount.
These data suggest that there is general agreement be-
tween the CUSUMs and the PSRs in determining which
centers have not achieved expected levels of performance,
though the CUSUMs did signal somewhat more often
than the PSRs using the signal limits established here,
especially in the kidney outcomes. This is not surpris-
ing, perhaps, given that the aim of the CUSUMs is to be
an early warning of potential difficulties. In general, the
CUSUMs identified centers much more quickly, often 1 to
2 years earlier, than the PSRs and could have provided an
opportunity for earlier intervention on the part of center
personnel.
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Table 1: The number of facilities flagged and average time to flagging in the Program Specific Reports compared to methods based on
one-sided and O-E CUSUMs for 1-year survival in 58 liver transplant programs
# and average time # and average time # and average time
for PSR flagging for one-sided CUSUM for O-E CUSUMFacility size
transplants/yr # facilities # Time (yrs) # Time (yrs) # Time (yrs)
8–20 4 1 3.50 1 1.76 1 1.76
20–50 20 2 3.00 2 0.68 2 0.68
50–100 25 6 3.25 8 2.06 8 2.01
100–140 7 1 3.00 1 3.27 1 3.27
140–185 2 0 NA 0 NA 0 NA
Conclusions and Discussion
The medical community is under increasing pressure to de-
velop and implement effective strategies to assess and im-
prove performance. The solid organ transplant community
has already established its leadership in this area, by col-
lecting and publicly reporting clinically valid, risk-adjusted
center-specific outcome data. Currently, these data are pri-
marily utilized in a regulatory fashion and are not particularly
well designed for improving practice in an ongoing fashion.
The implementation of a real-time, clinically relevant sys-
tem of outcomes monitoring with CUSUMs may acceler-
ate efforts to improve both transplant outcomes and organ
utilization.
The CUSUMs discussed here depend on appropriate risk
adjustment and require substantial analytical development
to support them. In the case of posttransplant graft and
patient survival, there is substantial experience in risk eval-
uation and adjustment through the ongoing efforts of the
SRTR and the OPTN organ-specific committees. As noted
earlier, however, it is important to continually review these
models to be sure that important baseline patient charac-
teristics are included. If the center leadership misunder-
stands the CUSUM results, there is the potential of inap-
propriate reactions, such as a decision to limit access to
high-risk transplants. It should be noted, however, that ap-
propriate adjustment takes these high risks into account
in defining the CUSUMs and limiting access to high-risk
transplants would not necessarily result in any measured
improvement in center performance.
Table 2: The number of facilities flagged and average time to flagging in the Program Specific Reports compared to methods based on
one-sided and O-E CUSUMs for 1-year survival in 100 kidney transplant programs
# and average time # and average time # and average time
for PSR flagging for one-sided CUSUM for O-E CUSUMFacility size
Transplants/yr # facilities # Time (yrs) # Time (yrs) # Time (yrs)
8–20 3 0 NA 1 1.00 1 1.00
20–50 27 5 3.20 8 1.51 8 1.52
50–100 37 2 3.00 5 1.92 5 1.91
100–140 17 0 NA 3 0.75 3 0.75
140–180 9 1 3.00 3 1.03 3 1.03
180–220 7 1 3.00 1 1.22 1 1.22
The signaling thresholds in the one-sided and O-E CUSUM
are designed to help the clinician understand when the
differences are of sufficient magnitude that a review is
suggested and help avoid premature or unjustified reac-
tion to apparent trends. As proposed here, the CUSUM
would not be a regulatory tool. Rather, as a quality im-
provement tool, it can be used to assess the clinical
impact of changing practices (e.g. accepting higher risk
donors). Thus, the CUSUM can help the center avoid com-
ing to the attention of the MPSC and will not increase
scrutiny. As noted, there is an excellent agreement be-
tween the methods in identifying which centers are at
risk; the real difference in the two methods is the rate of
ascertainment.
CUSUM charts have been clinically applied in a variety of
surgical applications in single-center series to assess out-
comes of cardiac surgery (18–21), colorectal surgery (22),
breast surgery (23) and other specialties (7). In general,
CUSUM charts have been used for two purposes: first, to
assess the learning curve inherent in the adoption of new
surgical procedures (e.g. laparoscopic nephrectomy) (24),
and second, to assess the outcome of a system of care
within a single institution or across a group of providers.
In the case of the learning curve, the CUSUM chart is fol-
lowed until the number of observed events is consistently
less than expected. The CUSUM chart can be effectively
used to monitor processes for either clusters of failures
or a steady change in outcomes (either positive or nega-
tive), providing that an appropriate one- or two-sided chart
is used.
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h –the rise in the arm corresponding to the
distance (d) from origin to vertex
Figure 4. An O-E CUSUM and as-
sociated V-mask. The V-mask gen-
erates a signal at the indicated
time t.
In this paper, we have concentrated on methods associ-
ated with monitoring mortality or graph survival outcomes
with a CUSUM method based on the Cox regression
model. This method is able to utilize all failures as they
occur and avoids the waiting time required in the assess-
ment of survival outcomes, using CUSUMs for binary out-
comes as previously reported (10,11,13–15). We feel that
these methods represent a major advance over previously
published techniques. Because the risk-adjustment mod-
els are consistent with those used in the SRTR’s PSRs,
center directors can feel confident that the CUSUM will
respond to clinically relevant changes in outcomes that
may be under the center’s control but will not penalize pro-
grams that transplant higher risk patients or utilize high-risk
organs. Furthermore, the utility of the CUSUM for ongoing
management is enhanced by its ability to capture and in-
clude all patient deaths and graft failures immediately upon
reporting rather than waiting, for example, for a full-year
posttransplant.
It should be noted that CUSUM techniques could be used
to monitor many other outcomes besides survival. The
methods based on a binary outcome, for example, could
be used to monitor such outcomes as conversion rates
or acceptance rates, in addition to short-term survival. In
the industrial context, CUSUMs were initially developed to
monitor normally distributed outcomes; normal CUSUMs
Table 3: Simulated power and average run length (ARL) for one-sided and O-E CUSUMs for a 1-year survival, assuming a base national
average 1-year death rate of 13.1%∗. The values of L and h and d (for the V-mask) are chosen to yield signals with probability 8% over
3.5 years for a facility of the given size operating at the national rate
One-sided CUSUM O-E CUSUM (with V-mask)Facility size
(transplants/yr) L Power ARL (yrs) h h/d Power ARL (yrs)
10 2.4 0.63 24.6 3.4 0.44 0.59 27.1
40 3.8 0.94 33.5 5.2 0.44 0.94 30.1
80 4.5 0.99 35.1 6.4 0.44 0.99 36.1
120 4.9 1.00 30.9 7.0 0.44 1.00 33.5
160 5.2 1.00 30.4 7.4 0.44 1.00 30.1
∗13.1% is the overall national 1-year death rate for liver transplants.
could be used to monitor other transplant outcomes such
as measures of quality of life or creatinine clearance.
Notably, there have been no prospective clinical trials in
surgical fields demonstrating that CUSUM charting is effec-
tive in a multicenter context. Previous analyses, including
our own (11), have all been retrospective. We hope that
by increasing knowledge of the techniques and collect-
ing prospective data we can demonstrate the advantages
of this methodology and gain support from OPTN mem-
bers to adopt it. We are currently undertaking a prospec-
tive study of these techniques with a limited number of
transplant centers and this work may help to fill this void.
From the retrospective studies, however, it seems likely
that there are substantial gains to be had through the ear-
lier identification of poorer center performance that the
CUSUM techniques can help to affect.
There appears to be two major barriers to widespread
adoption of CUSUM in the transplant community. First,
there is limited familiarity and comfort with using this
method of assessing outcomes. Second, some center
directors may fear that CUSUM will be used as yet an-
other regulatory tool to identify and censure poor perfor-
mance. As proposed here, however, CUSUM would be pro-
vided confidentially to individual centers as a management
tool to help them improve their own performance. One
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Table 4: Simulated power and average run length (ARL) for one-sided and O-E CUSUMs for a 1-year survival, assuming a base national
average 1-year death rate of 7.2%∗. The values of L and h and d (for the V-mask) are chosen to yield signals with probability 8% over 3.5
years for a facility of the given size operating at the national rate
One-sided CUSUM O-E CUSUM (with V-mask)Facility size
(transplants/yr) L Power ARL(yrs) L Power Power L
10 2.1 0.44 28.2 2.9 0.44 0.45 29.2
40 3.3 0.80 30.6 4.6 0.44 0.79 30.6
80 3.9 0.95 32.0 5.5 0.44 0.94 30.2
120 4.4 0.99 32.9 6.2 0.44 0.99 30.6
160 4.6 1.00 29.4 6.7 0.44 1.00 31.1
200 4.9 1.00 27.8 7.2 0.44 1.00 29.8
∗7.2% is the overall national 1-year death rate for kidney transplants.
danger with CUSUM charts is that users may react to
small trends in the charts that arise by random varia-
tion and look to examine and revise the process when
such change is unnecessary and perhaps even detrimen-
tal. This risk can be minimized through adequate edu-
cation and appropriate determination of signaling thresh-
olds. The signal from a CUSUM is a useful indicator, but
not definitive proof, of a change in center performance.
As a tool for quality improvement, the CUSUM chart
both validates the success of practice changes and can
trigger for a comprehensive review and examination, if
needed.
Organ transplantation offers an unparalleled opportunity to
restore life through the provision of a precious resource.
Patients, payers and the press are all interested in systems
of increased transparency of outcomes to ensure that the
limited supply of organs is optimally used. To obviate any
need for additional regulations, the transplant community
would be well served to adopt state-of-the-art monitoring
systems to improve performance and maximize the benefit
of the limited supply of donor organs.
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Statistical Methods Appendix
Calculation of the continuous CUSUM
Utilizing national data, a Cox proportional hazards model is
used to characterize the outcome of interest, such as pa-
tient survival, following liver transplant. The current SRTR
models for posttransplant survival (or graft survival) can
provide the basis for this, and by incorporating appropriate
clinical and donor characteristics, an estimated probability
of each patient’s survival for each day following transplant
can be determined. The CUSUM is then constructed by
examining all the individuals who have been transplanted
since the day the chart was initiated. The change in the
CUSUM on day t depends on the observed number of pa-
tient deaths (dt) and the risk-adjusted expected number of
patient deaths (et) on each day as derived from the model.
The CUSUM is then recalculated daily, incorporating both
longer survival times as well as the experience of new
transplants. This method can be used to track outcomes
such as mortality over a specified period of time (e.g. 1
year) posttransplant. In this case, patients who are more
than 1-year posttransplant would not be included in the
CUSUM calculation.
One-sided CUSUM: This CUSUM is constructed by con-
sidering a test of the hypothesis that the actual mortality
rate in the institution of interest is the same as that of the
population in general (relative risk [RR] = 1) versus an al-
ternative in which the mortality rate is a multiple (RRA >
1) of the overall death rate. This relative risk RRA is cho-
sen to correspond to an increase in the mortality rate that
would be considered clinically important. In what follows,
we consider a relative risk of RRA = 2, or a doubling of
the risk of death as the alternative of interest. In calcu-
lating the change in the CUSUM on day t, each death on
day t increases the CUSUM by an amount (0.69) and this
is reduced by subtracting et, the risk-adjusted number of
deaths expected. Thus, the value of the CUSUM (Ut) on
day t is Ut = Ut−1 + 0.69dt – et, where dt is the observed
number of deaths. In the one-sided CUSUM, the sum is
restricted so as to never become negative. Thus, if it be-
comes negative, its value is replaced by 0. For example,
suppose that 30 days into the CUSUM, one patient dies
(dt = 1) whereas the model predicts that on average et
= 0.05 patients would die on that day. The CUSUM would
increase by 0.69 − 0.05 = 0.64. On the other hand, if there
were no deaths on that day (dt = 0), the CUSUM would
decrease by the value 0.05. If the CUSUM became nega-
tive because of this adjustment, it would take the value 0.
Once the CUSUM achieves the value 0 it stays there until
the next death. Thus, the one-sided CUSUM will increase
when failures occur but will decrease only to 0 with a long
period of no deaths.
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The one-sided CUSUM signals that a process review is ap-
propriate when the CUSUM (Ut) exceeds some prespeci-
fied level L. An appropriate method for choosing L is still
the subject of investigation and is largely an empirical pro-
cess. On the one hand, we wish to choose L so that there
will tend to be a long waiting time until a signal occurs if the
institution has failure rates that are equal to or better than
the national average. On the other hand, if the death rates
of the facility are substantially in excess of the national av-
erage, we would like to identify the problem as quickly as
possible. One approach is to choose L so that, given the
facility size (average number of transplants per year), there
would be a prespecified probability of achieving a signal
over a given period of time if, in fact, the facility death rates
were exactly at the national rate. In this work, we adopted
this approach and the level was chosen to achieve a ‘false
positive rate’ of about 8% over a 3.5-year period. This is a
comparable false positive rate to the screening methods
currently in use by the SRTR and the MPSC. The average
length of time prior to signaling, referred as the average run
length (ARL), is one way of assessing a specified control
limit. Ideally, the ARL should be long for centers that are
in control (i.e. operating at the national average or better)
and short for centers that have high failure rates.
Two-sided or O-E CUSUM: This chart plots, as a function
of time, the difference between the observed number of
deaths Ot up to a given time t and Et, the number of
deaths that would be expected up to time t if the death
rate at the center was exactly the same as for the overall
national average. Thus, the O-E chart involves plotting Ot –
Et versus t, where Ot = d1 + d2 + . . . + dt and Et = e1 +
e2 + . . . + et for t = 1, 2, . . . .
The V-mask, introduced by Barnard, provides a way of
determining signals from a two-sided CUSUM (O-E plot)
(15,16). This is a somewhat more complicated approach
to determining signals than that available in the one-sided
CUSUM. The V-mask is applied at each time t and consists
of constructing a horizontal V with vertex located a given
distance (h/k) to the right of the current plotting position
(t, Ot –Et), where the arms of the V are chosen to pass
through points h units above and h units below the cur-
rent plotting position. The V-mask is defined by the choice
of h and k and we have selected these values in order
to achieve a false signal rate of approximately 8% over a
3.5-year period, in the same manner as the choice of the
control limit, L, in the one-sided CUSUM chart. An O-E
CUSUM along with an associated V-mask is illustrated in
Figure 4. The V-mask yields a signal at time t if the arms
of the V intersect the previous path of the CUSUM. If the
upper (lower) arm crosses the path, the rate of events at
the corresponding center is significantly less (greater) than
the national average. In the plot in Figure 4, the CUSUM
has signaled at the indicated time t with an indication that
the failure rates are significantly higher than the national
average at this center. It is at this time that the V-mask
signal would call for a review to determine whether there
are correctable causes of the observed high rate of fail-
ures. The subsequent path shown in the figure was that
observed without any such review.
Determination of an appropriate signaling threshold:
To determine an appropriate level of L and shape of the
V-mask, we designed a simulation study modeled on sur-
vival outcomes for liver transplant programs (Table 3). The
simulation is constructed so that the rate of false alarms
is set to be approximately 8% for a 3.5-year period. This
choice is similar to the criteria currently used by the SRTR,
in which a significance test of the null hypothesis at the
5% level is conducted every 6 months for a moving win-
dow length of 2.5 years. The reported control limit is for a
1-year death rate of 13.09%, which corresponds to the na-
tional average of 1-year mortality rate for liver transplants.
The continuous CUSUM charts (both the one-sided and
two-sided O-E V-mask charts) are designed to be sensi-
tive to a relative risk of RRA = 2, as compared to the
national average. From Table 3, it is clear that the choice of
a limit by this criterion is significantly affected by the size
of the transplant program. By adjusting L, the potential for
a false positive CUSUM signal can be made approximately
equal regardless of the program size. The column entitled
‘Power’ specifies the probability that a center whose rela-
tive risk is RR = 2 would signal in the 3-year period. The
ARLs in the table give the average number of years of
follow-up before the first signal would occur in a center
whose failure rates are at the national average (RR = 1).
In the review of liver transplant programs described in the
main article, we utilize the control limits as obtained from
this simulation.
Table 4 gives similar results from a simulation modeled on
1-year graft survival in national kidney transplant programs,
in which the rate of 1-year graft failure is 7.24%. Here again
the probability of false signal is set at 8% over the 3.5-year
period. The control limits from this simulation were used
in setting control limits for the study of kidney transplant
programs in the main article. We see from this table that
the signal threshold (L) increases with program size to re-
duce the likelihood of inappropriate signaling. Once the
volume is about 40 transplants per year, there is a 90%
likelihood that a true signal would be detected, and a period
of nearly 30 years expected between false positive signals
(ARL).
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